Rhodes Helen L, Thomas Peter, Sporik Richard, Holgate Stephen T, Cogswell Jeremy J
Department of Paediatrics, Poole Hospital, Poole; Dorset Research and Development Support Unit, Poole Hospital/Bournemouth University, Bournemouth, United Kingdom.
Am J Respir Crit Care Med. 2002 Jan 15;165(2):176-80. doi: 10.1164/ajrccm.165.2.2104032.
This study describes the natural history of atopic and wheezy disorders from birth to adult life in a cohort at risk of atopy. One hundred subjects born in Poole, England, were selected at birth in 1976 on the basis that at least one parent was atopic. Subjects were examined annually in the preschool years, and at the ages of 11 and 22 yr. Skin prick tests and total serum immunoglobulin E (IgE) were performed at each visit, and at 11 and 22 yr, bronchial hyperresponsiveness (BHR) to inhaled histamine was measured. Sixty-three subjects remained on follow-up at 22 yr. The annual prevalence of both wheeze and atopy increased with age. Twenty-five percent of adults showed both wheeze and BHR (asthma). Remission of wheeze was common in subjects younger than 5 yr of age and likely if wheezing occurred on less than two occasions, but wheeze at 11 yr was likely to persist. Sixty percent of the adult subjects with asthma developed sensitivity to common allergens by the age of 2 yr and were showing BHR by mid-childhood. Sensitization to dietary allergens occurred in infancy and waned after early childhood but predicted the early sensitization to inhalant allergens. In conclusion, adults with asthma can begin wheezing at any age but tend to sensitize early and have abnormal airway characteristics by the age of 11 yr.
本研究描述了一组有特应性风险人群从出生到成年期特应性和喘息性疾病的自然病程。1976年在英国普尔出生的100名受试者在出生时被选中,入选标准是至少有一位家长患有特应性疾病。在学龄前以及11岁和22岁时对受试者进行年度检查。每次就诊时均进行皮肤点刺试验和血清总免疫球蛋白E(IgE)检测,在11岁和22岁时测量对吸入组胺的支气管高反应性(BHR)。63名受试者在22岁时仍在接受随访。喘息和特应性的年患病率均随年龄增长而增加。25%的成年人同时出现喘息和BHR(哮喘)。喘息缓解在5岁以下的受试者中很常见,如果喘息发作少于两次则很可能缓解,但11岁时的喘息很可能会持续。60%的成年哮喘患者在2岁时对常见过敏原致敏,并在童年中期出现BHR。对食物过敏原的致敏发生在婴儿期,幼儿期后减弱,但可预测对吸入性过敏原的早期致敏。总之,成年哮喘患者可在任何年龄开始喘息,但往往早期致敏,并在11岁时出现气道特征异常。